兴齐眼药：上半年净利润同比增长97.75% 拟10派7元

Group 1 - The company, Xingqi Eye Medicine, reported a revenue of 1.163 billion yuan for the first half of 2025, representing a year-on-year growth of 30.38% [1] - The net profit attributable to shareholders reached 335 million yuan, showing a significant year-on-year increase of 97.75% [1] - The basic earnings per share were reported at 1.36 yuan, and the company proposed a cash dividend of 7 yuan per 10 shares (tax included) [1]